Elevated transmembrane protein TMEM230 in GBM can promote tumor cell migration, extracellular stent remodeling, and excessive blood vessels and abnormal formation of blood vessels, so TMEM230 has the potential be a therapeutic target for inhibition of GBM tumor cells and anti-angiogenesis 36. The gene discussed is TMEM230; the disease is glioblastoma.